Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis

Published:2018-05-10 Issue:1 Volume:68 Page:7-9
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hernaez Ruben¹²³^ORCID,Kanwal Fasiha¹²³,El-Serag Hashem B.¹²³

Affiliation:

1. Section of Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center; Houston TX

2. Center for Innovations in Quality, Effectiveness and Safety (IQuESt); Michael E. DeBakey Veterans Affairs Medical Center; Houston TX

3. Section of Gastroenterology and Hepatology, Department of Medicine; Baylor College of Medicine; Houston TX

Funder

PHS

Houston VA HSR&D Center of Innovations of Quality, Effectiveness and Safety

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29776/fullpdf

Reference10 articles.

1. Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the united states;Yang;Clin Gastroenterol Hepatol,2017

2. Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis;Yang;Hepatology,2018

3. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents;Kanwal;Gastroenterology,2017

4. Number-needed-to-treat (NNT)-needs treatment with care;Christensen;Basic Clin Pharmacol Toxicol,2006

5. Role of age and race in the risk of hepatocellular carcinoma in veterans with hepatitis B virus infection;Mittal;Clin Gastroenterol Hepatol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center;Abdominal Radiology;2021-07-20

2. Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis;BioMed Research International;2021-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3